Increased Ly6Clo and decreased Ly6Chi circulating monocytes suggest more patrolling of endothelium and less systemic inflammatory burden induced by CD11b modulation, which is likely also a contributing factor in how positive modulation of CD11b results in reduced tumor growth in vivo. This evidence concerns the gene ITGAM and neoplasm.